To develop an effective anti-tumor immune response that will result in immune-mediated tumor eradication, a concerted effort of antigen-presenting cells (APCs) (DCs, macrophages), lymphocytes (CD8, CD4) and NK cells is required. Here, CD8A is linked to neoplasm.